Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
National Health Research Institutes academic institution, Taiwan • Dr. Hsiu-Jung Lo, Investigator • Expertise: Infectious Diseases and Vaccinology • Objectives of proposal: Develop vaccines and antimicrobial drugs for managing infectious diseases • Partnership: Potential collaborator for 2.3.1 Anti-microbial drug resistance: Dr. Remko van Leeuwen, CEO at Madam Therapeutics, Amsterdam, Netherlands • Specific topics : 1.3 Suitability, safety, efficacy of therapies 1.4 Innovative therapeutic approaches and interventions. 2.3.1 Anti-microbial drug resistance 2.3.3 Potentially new and re-emerging epidemics www.nhri.org.tw 2.3.4 Neglected infectious diseases National Health Research Institutes academic institution, Taiwan • Dr. Pinpin Lin, Investigator • Expertise, the objectives of proposal: Toxicology; Safety evaluation for nanoparticles and mechanistic studies for environmental chemicals-induced lung arcinogenesis. • Partnership: Invited by Prof. Jean-Pierre Locquet, Solid State Physics and Magnetism Section, Katholieke Universiteit Leuven, Leuven, Belgium for the application of FP7-NMP2012-SMALL-6. • Specific topics : Health.2013.1.3-1: Modelling toxic responses in case studies for predictive human safety assessment. FP7HEALTH-2013-INNOVATION-1 www.nhri.org.tw National Health Research Institutes academic institution, Taiwan • Dr. Ko-Jiunn Liu, Associated Investigator • Expertise: Tumour Immunology, Tumor and surrounding cell interaction • Objective of proposal: Cell and antibody-based immunotherapy • Partnership: Plan to collaborate with Prof. Gerold Schuler, University Hospital Erlangen, Erlangen, Germany • Specific topics : Topic 2.4.1, Cell and antibody-based immunotherpy www.nhri.org.tw